Peter Múdrý
Masaryk University(CZ)University Hospital Brno(CZ)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Antifungal resistance and susceptibility, Fungal Infections and Studies, Bone Tumor Diagnosis and Treatments, Tumors and Oncological Cases
Most-Cited Works
- → Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial(2019)232 cited
- → Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial(2018)182 cited
- → Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience(2016)123 cited
- → Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience(2012)85 cited
- → Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study—EpSSG NRSTS 2005(2016)82 cited
- → Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)